Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Suzhou Suncadia Biopharmaceuticals Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Triple threat: new combo aims to outsmart advanced liver cancer Results expected Sep 2026 (estimated)
- New dermatitis drug candidate begins first human safety tests Results expected Oct 2026 (estimated)
- New hope for advanced cancer: experimental drug SHR-1681 enters human trials Results expected Nov 2026 (estimated)
- New hope for EGFR lung cancer: experimental drug SHR-A2009 takes on chemo in phase 3 trial Results expected Dec 2026 (estimated)
- Can a new drug tame metastatic prostate cancer? a phase 1 trial aims to find out Results expected Dec 2026 (estimated)